Truist Financial’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-150,000
| Closed | -$843K | – | 2850 |
|
|
2021
Q4 | $843K | Sell |
150,000
-5,000
| -3% | -$28.1K | ﹤0.01% | 1713 |
|
|
2021
Q3 | $992K | Sell |
155,000
-65
| -0% | -$416 | ﹤0.01% | 1602 |
|
|
2021
Q2 | $1.31M | Buy |
155,065
+36,065
| +30% | +$304K | ﹤0.01% | 1490 |
|
|
2021
Q1 | $1.25M | Sell |
119,000
-21,000
| -15% | -$220K | ﹤0.01% | 1446 |
|
|
2020
Q4 | $2.37M | Buy |
140,000
+16,000
| +13% | +$271K | ﹤0.01% | 1096 |
|
|
2020
Q3 | $1.59M | Buy |
124,000
+10,000
| +9% | +$128K | ﹤0.01% | 1158 |
|
|
2020
Q2 | $1.61M | Buy |
114,000
+30,000
| +36% | +$423K | ﹤0.01% | 1117 |
|
|
2020
Q1 | $773K | Buy |
84,000
+32,000
| +62% | +$294K | ﹤0.01% | 1355 |
|
|
2019
Q4 | $775K | Buy |
+52,000
| New | +$775K | ﹤0.01% | 1563 |
|